Skip to content
GLP-1 Desk
Menu
Dispatch #104

MyDrHank

Every price MyDrHank advertises is the cheapest rung of a four-term ladder — its own code renders the annual-prepay rate as “From $X/mo”, so the month-to-month cost of $349 tirzepatide and $259 semaglutide appears nowhere in the marketing.

Visit MyDrHank ↗Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way.
Semaglutide
$259/mo month-to-month (compounded injectable; oral $249/mo; the advertised $171/mo is a $2,057 annual prepay)
Tirzepatide
$349/mo month-to-month (compounded; the advertised $240/mo is a $2,883 annual prepay)
Coverage
44 states (excludes Kansas, Louisiana, Mississippi, New Mexico, North Dakota, West Virginia)
Brand-name
Compounded only

Weigh MyDrHank against the full ranked field on the best semaglutide providers ranking, or line it up against its closest alternatives. Or go one-on-one: MyDrHank vs CoreAge Rx. Because MyDrHank dispenses compounded medication, it’s worth understanding whether compounded GLP-1 is legit and safe.

Desk Score breakdown

Each of the six scored dimensions. See the methodology.

Price transparency52/100
State access72/100
Molecule range88/100
Onboarding speed88/100
Support responsiveness74/100
Licensing & trust76/100

What the Desk likes

  • A genuine month-to-month option exists on every line — $349/mo tirzepatide, $259/mo injectable semaglutide, $249/mo oral — so nothing forces a commitment on a reader who reads the ladder
  • Priced per product and per term rather than per milligram, so titrating up costs nothing extra — the charge most compounded programs raise as you climb doses
  • A real oral semaglutide alongside the injection and within $10/mo of it, plus an ondansetron-combined tablet aimed at nausea during titration
  • Free consultation, free shipping and no insurance required
  • Clean FDA record — screened against the FDA warning-letter database in August 2026 with zero hits

Where points come off

  • Every advertised price is an annual-prepay minimum. The site's own code takes the cheapest rung of a four-term ladder and prints it as “From $X/mo”, so the $240/mo tirzepatide and $171/mo semaglutide it markets are what $2,883 and $2,057 paid up front work out to per month — the month-to-month rates, $349 and $249, are displayed nowhere, and the FAQ still calls the prepay figure a plan with “no contract”
  • One advertised figure is purchasable at no tier — the funnel's pricing footnote quotes “$200/mo for compounded tirzepatide”, and MyDrHank's own four tirzepatide prices are $349, $297, $267 and $240 per month
  • No served-states list on the consumer pages — the six excluded states (Kansas, Louisiana, Mississippi, New Mexico, North Dakota, West Virginia) are documented in the affiliate terms, not anywhere a shopper can read them
  • Compounded semaglutide and tirzepatide are not FDA-approved — not the same product as Wegovy, Ozempic or Zepbound, and there is no brand-name lane here
  • No pharmacy, prescriber or medical director named — the product page says only that the medication is “compounded in an FDA-registered U.S. pharmacy”

The Desk's briefing — C

Best for: Readers who intend to pay for a full year up front and will do the arithmetic first — at the month-to-month rate this is one of the dearer compounded desks the Desk tracks.

MyDrHank ranks #104 of 508 providers scored — see #1, CoreAge Rx here.

Visit MyDrHank ↗

Related dispatches

Everyone else here (18)

Pricing and verification reflect MyDrHank's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on MyDrHank's site. Not medical advice; see our disclosure.

← Back to The Desk